Nattanan Jiwacharoenchai

4-aryl-N-phenylpyrimidin-2-amines Targeting EGFR-tyrosine kinase attenuated EGFR-expressing cell lines

M. Gleeson, K. Choowongkomon, Duangnapa Kiriwan, 2022, European Journal of Medicinal Chemistry Reports.

A novel cyclic NP1 reveals obstruction of EGFR kinase activity and attenuation of EGFR‐driven cell lines

K. Choowongkomon, Chomdao Sinthuvanich, Duangnapa Kiriwan, 2021, Journal of cellular biochemistry.

Identification of tripeptides against tyrosine kinase domain of EGFR for lung cancer cell inhibition by in silico and in vitro studies

S. Sousa, K. Choowongkomon, Napat Songtawee, 2021, Chemical biology & drug design.

Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation.

K. Choowongkomon, S. Ruchirawat, Chatchakorn Eurtivong, 2022, Bioorganic & medicinal chemistry letters.

The Effect of the EGFR - Targeting Compound 3-[(4-Phenylpyrimidin-2-yl) Amino] Benzene-1-Sulfonamide (13f) against Cholangiocarcinoma Cell Lines

M. Gleeson, K. Choowongkomon, V. Kukongviriyapan, 2021, Asian Pacific journal of cancer prevention : APJCP.